Sanofi Ventures

Corporate VC Cambridge, United States ·Founded 2012

Overview

Sanofi Ventures is the corporate venture capital arm of Sanofi, investing globally in early-stage biotech and digital health companies aligned with Sanofi’s mission. Since its inception in 2012, Sanofi Ventures has deployed over $800 million across more than 70 innovative companies in biotech and digital health. The fund focuses on areas such as immunology, rare diseases, neurology, and vaccines, investing across all stages of the private company lifecycle, from Seed to Series B and beyond. Sanofi Ventures leads financings, serves on boards, and works alongside portfolio companies to drive long-term value. In September 2025, Sanofi committed an additional $625 million to Sanofi Ventures, increasing its total assets under management to over $1.4 billion. This commitment aims to accelerate investment in biotech and digital health innovation, supporting Sanofi’s long-term growth strategy. The fund's evergreen structure allows it to invest in early-stage companies that are too early to partner with or acquire, serving as an entry point to the innovation ecosystem for Sanofi. Sanofi Ventures has a diverse, globally distributed portfolio of companies advancing innovation around the world. The fund's strategic importance is highlighted by its recent performance, including three realized exits in 2024 with a combined acquisition value of $3.25 billion. By providing essential financial backing and strategic support, Sanofi Ventures plays a crucial role in advancing healthcare innovation and reinforcing Sanofi’s position as a leading catalyst for breakthrough science in healthcare.

Investment Focus

  • Focus on biotech and digital health companies
  • Alignment with Sanofi’s mission
  • Early-stage companies
  • Potential for long-term value creation

Portfolio Companies

Formation BioVicebioVigil Neuroscience

Get the full list of 54,000+ investors

Sanofi Ventures and every other firm and angel in the database — as one spreadsheet you keep.

$19one-time payment · no subscription
  • All 54,000+ investors — VC firms, private equity, family offices and angels
  • The key person to contact at each one, with their job title
  • Their work email address
  • Their phone number
  • Their LinkedIn profile
  • Delivered as a single .xlsx file — download it as many times as you like
Get the full list — $19 → One payment. No seats, no credits, no expiry. Already bought it? Sign in to download it again — no second payment.

Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.

Frequently asked questions about Sanofi Ventures

What sectors does Sanofi Ventures invest in?

Sanofi Ventures invests in Healthcare, Artificial Intelligence, Digital Health, Pharmaceuticals, Medical Devices and Diagnostics, and is based in Cambridge, United States. Sanofi Ventures is listed as a corporate vc in the ConnectSafely investor database.

What stage does Sanofi Ventures invest at?

Sanofi Ventures backs companies at Seed, Series A, Series B, Growth, Late Stage and Pre-IPO, writing cheques of 1M - 50M.

Which regions does Sanofi Ventures invest in?

Sanofi Ventures invests across United States, United Kingdom, Canada, Germany, Japan and Australia.

Who are the partners at Sanofi Ventures?

Team members listed for Sanofi Ventures include Kriti Subramanyam (Director of Digital Investments).

What companies has Sanofi Ventures invested in?

Sanofi Ventures's portfolio includes Formation Bio, Vicebio and Vigil Neuroscience.

How do I contact Sanofi Ventures?

Sanofi Ventures's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.

Last updated · Source: ConnectSafely investor database